Literature DB >> 24369082

Tumor necrosis factor inhibitors for inflammatory bowel disease.

Mehmet Coskun, Ole Haagen Nielsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24369082     DOI： 10.1056/NEJMc1312800

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Inflammatory pathways of importance for management of inflammatory bowel disease.

Authors:  Jannie Pedersen; Mehmet Coskun; Christoffer Soendergaard; Mohammad Salem; Ole Haagen Nielsen
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

Review 2.  Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease.

Authors:  Philip E Dubé; Shivesh Punit; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-04       Impact factor: 4.052

Review 3.  New strategies for treatment of inflammatory bowel disease.

Authors:  Ole Haagen Nielsen
Journal:  Front Med (Lausanne)       Date:  2014-03-24

4.  Decoy exosomes as a novel biologic reagent to antagonize inflammation.

Authors:  Natalie Duong; Kevin Curley; Annie Brown; Alexander Campanelli; Mai Anh Do; Daniel Levy; Adarsh Tantry; Gerard Marriott; Biao Lu
Journal:  Int J Nanomedicine       Date:  2019-05-09

5.  miR-642a-5p increases glucocorticoid sensitivity by suppressing the TLR4 signalling pathway in THP-1 cells.

Authors:  Juan Luo; Yijie Wang; Xiangqian Dong; Wen Wang; Yanju Mu; Yang Sun; Fengrui Zhang; Yinglei Miao
Journal:  Biochem Biophys Rep       Date:  2022-09-27

6.  GL-V9, a new synthetic flavonoid derivative, ameliorates DSS-induced colitis against oxidative stress by up-regulating Trx-1 expression via activation of AMPK/FOXO3a pathway.

Authors:  Yue Zhao; Yang Sun; Youxiang Ding; Xiaoping Wang; Yuxin Zhou; Wenjun Li; Shaoliang Huang; Zhiyu Li; Lingyi Kong; Qinglong Guo; Na Lu
Journal:  Oncotarget       Date:  2015-09-22

7.  Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy.

Authors:  Xinyu Wang; Junjie Yan; Lizhen Wang; Donghui Pan; Yuping Xu; Fang Wang; Jie Sheng; Xinxin Li; Min Yang
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.